1-Hydroxybenzotriazole → HCID 131731158, compound

HRID 473525Notes

Reaction equation

HRID 473525 reaction equation
[NH:1](C(OCC1C2C(=CC=CC=2)C2C1=CC=CC=2)=O)[C@H:2]([C:4]([NH:6][CH2:7][C:8]([OH:10])=O)=[O:5])C.[NH2:28][C@H:29]([CH:37]=[O:38])[CH2:30][C:31]1[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=1.[CH3:39]N(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=CC2N(O)N=NC=2C=1.C(N(C(C)C)CC)(C)C>CN(C)C=O.ClCCl>[NH2:28][C@H:29]([C:37]([NH:1][CH2:2][C:4]([NH:6][C@H:7]([CH:8]=[O:10])[CH3:39])=[O:5])=[O:38])[CH2:30][C:31]1[CH:32]=[CH:33][CH:34]=[CH:35][CH:36]=1

Participants

8

Procedure

Similar to comparative example 4, CTC-phenylalanine (Phe)-H was synthesized by the solid phase reaction method using CTC as a solid phase carrier. Furthermore, similar to Example 7, Fmoc-Ala-Gly-OH was synthesized. Then, to dichloromethane (2 ml) were added CTC-Phe-H (110 mg (0.145 mmol)), Fmoc-Ala-Gly-OH (160 mg (0.4 mmol)), HBTU (165 mg (0.4 mmol)), HOBt (60 mg (0.4 mmol)), dimethylformamide (1 ml) and diisopropylethylamine (75 μl (0.4 mmol)), respectively, and the mixture was stirred to react at room temperature for 2 hours. After the reaction, the solid phase was washed with dimethylformamide (3×2 ml), methanol (3×2 ml) and dichloromethane (3×2 ml), respectively. Subsequently, to the above solid phase was added the previously prepared Fmoc deprotection solution (dimethylformamide:piperidine:DBU=96:2:2) (2 ml), and the mixture was stirred to react at room temperature for 1 hour to obtain CTC-Phe-Gly-Ala-H.

Workup

  1. customwas synthesized by the solid phase reaction method
  2. customto react at room temperature for 2 hours
  3. customAfter the reaction
  4. washthe solid phase was washed with dimethylformamide (3×2 ml), methanol (3×2 ml) and dichloromethane (3×2 ml)
  5. additionSubsequently, to the above solid phase was added the previously prepared Fmoc deprotection solution (dimethylformamide:piperidine:DBU=96:2:2) (2 ml)
  6. stirringthe mixture was stirred
  7. customto react at room temperature for 1 hour

Sources & evidence

ORD record
ord-2343c4bba6eb414aa8bf4887751999f8
Source dataset
uspto-grants-2014_01
Patent number
US08633298B2

Reaction notes

Loading…